All News

Farah Amro, MD, shares her research at the 2025 ACOG ACSM on leaving the placenta in situ in select patients with placenta accreta spectrum.

Laurence Shields, MD, shares details from his latest study on hemorrhage control devices for postpartum hemorrhage at the 2025 ACOG ACSM.

A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found that while recurrent uterine rupture is rare, patients with a history of rupture face a significantly increased subsequent risk of preterm delivery.

A recent study presented at the 2025 ACOG Annual Clinical and Scientific Meeting found that most TikTok videos on hormonal contraception was misleading.

A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that a self-screening survey with educational videos enables most patients to determine medication abortion eligibility without an ultrasound.

A new study presented at 2025 ACOG Annual Clinical and Scientific Meeting found disparities between RSV uptake in pregnant patients.

In this Q&A, experts explain how ACOG’s tailored prenatal care model supports flexibility, equity, and shared decision-making in pregnancy.

Azithromycin and doxycycline carry a greater risk of vulvovaginal candidiasis compared to other acne treatments, researchers report at ACOG ACSM 2025.

A meta-analysis presented at 2025 ACOG Annual Clinical & Scientific Meeting found that elinzanetant demonstrated a reduction in VMS frequency and intensity.

Shared decision making and individualized strategies are emphasized in the new ACOG consensus.

A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that physiotherapy support during labor lowers the chances of cesarean delivery, severe perineal tears, and labor pain.

New research presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that mandatory in-person consent and waiting periods in Ohio create significant delays and barriers to abortion access.

A study found that nulliparous women with infertility, especially those using fertility treatments, face increased odds of cervical insufficiency and related pregnancy complications.

The nearly 4000 cases in 2023 were the highest number reported in over 30 years, the Task Force stated.

A quick look into some of the top sessions occurring at the 2025 ACOG Annual Clinical and Scientific Meeting, being held from May 16-18, 2025, in Minneapolis, Minnesota.

A new study finds that uterine-preserving procedures result in fewer complications, faster recovery, and lower recurrence rates compared to hysterectomy in pelvic organ prolapse treatment.

Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months.

New expert guidelines emphasize trauma-informed care and nonpharmacological techniques to reduce pain and improve patient experience during intrauterine device insertion.

The Teal Wand offers FDA-approved, accurate at-home cervical cancer screening for women aged 25 to 65 years, aiming to improve access and comfort while boosting screening rates.

A new study finds that higher physical activity levels in late pregnancy are linked to earlier labor onset and increased chances of vaginal delivery.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Research highlights buprenorphine’s effectiveness and safety in improving outcomes for pregnant patients with opioid use disorder, urging updates to medical guidelines.

A new study finds that temporarily stopping tamoxifen to achieve pregnancy does not increase short-term breast cancer recurrence in premenopausal women.

A new study reveals significantly increased abortion use among bisexual, lesbian, and mostly heterosexual individuals, underscoring gaps in reproductive health access.

New research shows that girls who eat healthier during childhood may start their periods later, potentially lowering their risk for chronic diseases such as diabetes and breast cancer.

A new study reveals significantly increased emergency department visit rates in the first year of life for infants born to women with physical, sensory, or developmental disabilities.

Devon Ramaeker, MD, dives into the expansion of prenatal genetic testing, improvements in early diagnosis of anomalies, and patient education.

A new study finds no significant difference in symptom improvement between onabotulinumtoxinA injections and midurethral sling surgery for women with mixed urinary incontinence.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.